Leila Amini

1.5k total citations · 2 hit papers
22 papers, 790 citations indexed

About

Leila Amini is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Leila Amini has authored 22 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Leila Amini's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and CRISPR and Genetic Engineering (4 papers). Leila Amini is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and CRISPR and Genetic Engineering (4 papers). Leila Amini collaborates with scholars based in Germany, United States and Belgium. Leila Amini's co-authors include Petra Reinke, Michael Schmueck‐Henneresse, Hans‐Dieter Volk, Dimitrios L. Wagner, Désirée J. Wendering, Levent Akyüz, Shannon L. Maude, Carlos A. Ramos, Sara Silbert and Renier J. Brentjens and has published in prestigious journals such as Nature Medicine, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Leila Amini

22 papers receiving 774 citations

Hit Papers

High prevalence of Streptococcus pyogenes Cas9-reactive T... 2018 2026 2020 2023 2018 2022 50 100 150 200 250

Peers

Leila Amini
Comparison fields: 5 of 80
  • Molecular Biology 431
  • Oncology 341
  • Genetics 180
  • Immunology 153
  • Biomedical Engineering 126
Replace Caroline L. Wiegerinck with:
Caroline L. Wiegerinck Netherlands
Evelien Kruisselbrink Netherlands
Eman A. Taha Japan
Rui Tian China
Lisa Zhao United States
Αndroulla N. Miliotou Greece
Sandrine Vessillier United Kingdom
Zhe Jing China
Yiwei Dong China
Yuexin Zhou China
Caroline L. Wiegerinck Netherlands View profile →
Citations per field, relative to Leila Amini
Leila Amini · 1×
Citations per year, relative to Leila Amini
Leila Amini · 1×

Countries citing papers authored by Leila Amini

Since Specialization
Citations

This map shows the geographic impact of Leila Amini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Amini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Amini more than expected).

Fields of papers citing papers by Leila Amini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Amini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Amini. The network helps show where Leila Amini may publish in the future.

Co-authorship network of co-authors of Leila Amini

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Amini. A scholar is included among the top collaborators of Leila Amini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Amini. Leila Amini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 5
3 22
4 29
5 3
6
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion breakdown →
204
7 9
8 38
9 26
10 14
11 37
12 5
13 9
14 3
15
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population breakdown →
293
16 17
17 13
18 16
19 40
20
STERILIZATION OF ESHERICHIA COLI AND THE MICROORGANISMS OF TURMERIC SAMPLES WITH CORONA DISCHARGE PLASMA
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026